Among them, blood lipid disorder in group 1 accounted for 30.5% and dyslipidemia in group 2 accounted for more than 13.9%, and 4.2% of patients with dyslipidemia group 3.
Trong đó, rối loạn lipid máu nhóm 1 chiếm 30,4%, nhóm 2 chiếm 13,9%, nhóm 3 chiếm 4,2%.